A gelatin-thrombin matrix topical hemostatic agent (Floseal) in combination with harmonic scalpel is effective in patients undergoing total thyroidectomy: A prospective, multicenter, single-blind, randomized controlled trial

Surgical Innovation

Volumn 23, Issue 1, 2016, Pages 23-29

  Docimo, Giovanni ^a   Tolone, Salvatore ^a   Conzo, Giovanni ^a   Limongelli, Paolo ^a   Del Genio, Gianmattia ^a   Parmeggiani, Domenico ^a   De Palma, Maurizio ^b   Lupone, Gennaro ^b   Avenia, Nicola ^c   Lucchini, Roberta ^c   Monacelli, Massimo ^c   Gulotta, Gaspare ^d   Scerrino, Gregorio ^d   Pasquali, Daniela ^a   Bellastella, Giuseppe ^a   Esposito, Katherine ^a   De Bellis, Annamaria ^a   Pezzolla, Angela ^e   Ruggiero, Roberto ^a   Docimo, Ludovico ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b CARDARELLI HOSPITAL   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d UNIVERSITY OF PALERMO   (Italy)

^e UNIVERSITY OF BARI   (Italy)

Author keywords

Floseal; gelatin thrombin matrix; harmonic scalpel; hemostatic agent; total thyroidectomy

Indexed keywords

CALCIUM; HEMOSTATIC AGENT; FLOSEAL MATRIX; GELATIN; GELATIN SPONGE; THROMBIN;

ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; DYSTONIA; FEMALE; GOITER; HEMOSTASIS; HUMAN; HYPOCALCEMIA; INTERMETHOD COMPARISON; LAPAROSCOPIC SHEAR; LARYNGOSCOPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NERVE PARALYSIS; OPERATION DURATION; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEROMA; SINGLE BLIND PROCEDURE; THYROID CARCINOMA; THYROID DISEASE; THYROIDECTOMY; ADVERSE EFFECTS; CLINICAL TRIAL; DEVICES; MIDDLE AGED; PROCEDURES; STATISTICS AND NUMERICAL DATA; SURGICAL EQUIPMENT; TREATMENT OUTCOME;

ADULT; FEMALE; GELATIN; GELATIN SPONGE, ABSORBABLE; HEMOSTATICS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SURGICAL INSTRUMENTS; THROMBIN; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 84952899266     PISSN: 15533506     EISSN: 15533514     Source Type: Journal    
DOI: 10.1177/1553350615596638     Document Type: Article

References (35)

1. Barney BM, Hitchcock YJ, Sharma P, Shrieve DC, Tward JD,. Overall and cause-specific survival for patients undergoing lobectomy, near-total, or total thyroidectomy for differentiated thyroid cancer. Head Neck. 2011; 33: 645-649.
2. Conzo G, Pasquali D, Bellastella G, et al. Total thyroidectomy, without prophylactic central lymph node dissection, in the treatment of differentiated thyroid cancer. Clinical retrospective study on 221 cases. Endocrine. 2013; 44: 419-425.
3. Palit TK, Miller CC 3rd, Miltenburg DM,. The efficacy of thyroidectomy for Graves' disease: a meta-analysis. J Surg Res. 2000; 90: 161-165.
4. Riju R, Jadhav S, Kanthaswamy R, Jacob P, Nair CG,. Is total thyroidectomy justified in multinodular goitre. J Indian Med Assoc. 2009; 107: 223-225.
5. Amaral JF,. The experimental development of an ultrasonically activated scalpel for laparoscopic use. Surg Laparosc Endosc. 1994; 4: 92-99.
6. Karvounaris DC, Antonopoulos V, Psarras K, Sakadamis A,. Efficacy and safety of ultrasonically activated shears in thyroid surgery. Head Neck. 2006; 28: 1028-1031.
7. D'Ajello F, Cirocchi R, Docimo G, et al. Thyroidectomy with ultrasonic dissector: a multicentric experience. G Chir. 2010; 31: 289-392.
8. Docimo G, Ruggiero R, Gubitosi A, et al. Ultrasound scalpel in thyroidectomy. Prospective randomized study. Ann Ital Chir. 2012; 83: 491-496.
9. Ecker T, Carvalho AL, Choe JH, Walosek G, Preuss KJ,. Hemostasis in thyroid surgery: harmonic scalpel versus other techniques-a meta-analysis. Otolaryngol Head Neck Surg. 2010; 143: 17-25.
10. Sugo H, Mikami Y, Matsumoto F, Tsumura H, Watanabe Y, Futagawa S,. Comparison of ultrasonically activated scalpel versus conventional division for the pancreas in distal pancreatectomy. J Hepatobiliary Pancreat Surg. 2001; 8: 349-352.
11. Sugo H, Matsumoto K, Kojima K, Fukasawa M, Beppu T,. Role of ultrasonically activated scalpel in hepatic resection: a comparison with conventional blunt dissection. Hepatogastroenterology. 2005; 52: 173-175.
12. Swanstrom LL, Pennings JL,. Laparoscopic control of short gastric vessels. J Am Coll Surg. 1995; 181: 347-351.
13. Ohtsuka T, Wolf RK, Wurnig P, Park SE,. Thoracoscopic limited pericardial resection with an ultrasonic scalpel. Ann Thorac Surg. 1998; 65: 855-856.
14. Blankenship DR, Gourin CG, Porubsky EA, et al. Harmonic scalpel versus cold knife dissection in superficial parotidectomy. Otolaryngol Head Neck Surg. 2004; 131: 397-400.
15. Pellegrino A, Fruscio R, Maneo A, et al. Harmonic scalpel versus conventional electrosurgery in the treatment of vulvar cancer. Int J Gynaecol Obstet. 2008; 103: 185-188.
16. Baxter Healthcare Corporation. Floseal Hemostatic Matrix, 10 Ml: instructions for use. http://www.baxter.com/downloads/healthcare-professionals/products/Floseal10ml-IFU-r3pdf. Accessed July 9, 2015.
17. Mozet C, Prettin C, Dietze M, Fickweiler U, Dietz A,. Use of Floseal and effects on wound healing and pain in adults undergoing tonsillectomy: randomised comparison versus electrocautery. Eur Arch Otorhinolaryngol. 2012; 269: 2247-2254.
18. Richter F, Schnorr D, Deger S, et al. Improvement of hemostasis in open and laparoscopically performed partial nephrectomy using a gelatin matrix-thrombin tissue sealant (Floseal). Urology. 2003; 61: 73-77.
19. Bak JB, Singh A, Shekarriz B,. Use of gelatin matrix thrombin tissue sealant as an effective hemostatic agent during laparoscopic partial nephrectomy. J Urol. 2004; 171: 780-782.
20. Wille AH, Johannsen M, Miller K, Deger S,. Laparoscopic partial nephrectomy using Floseal for hemostasis: technique and experiences in 102 patients. Surg Innov. 2009; 16: 306-312.
21. Oz MC, Cosgrove DM 3rd, Badduke BR, et al. Controlled clinical trial of a novel hemostatic agent in cardiac surgery. The Fusion Matrix Study Group. Ann Thorac Surg. 2000; 69: 1376-1382.
22. Nasso G, Piancone F, Bonifazi R, et al. Prospective, randomized clinical trial of the Floseal matrix sealant in cardiac surgery. Ann Thorac Surg. 2009; 88: 1520-1526.
23. Ellegala DB, Maartens NF, Laws ER Jr., Use of Floseal hemostatic sealant in transsphenoidal pituitary surgery: technical note. Neurosurgery. 2002; 51: 513-515.
24. Reuthebuch O, Lachat ML, Vogt P, Schurr U, Turina M,. Floseal: a new hemostyptic agent in peripheral vascular surgery. Vasa. 2000; 29: 204-206.
25. Weaver FA, Hood DB, Zatina M, Messina L, Badduke B,. Gelatin-thrombin-based hemostatic sealant for intraoperative bleeding in vascular surgery. Ann Vasc Surg. 2002; 16: 286-293.
26. Renkens KL Jr, Payner TD, Leipzig TJ, et al. A multicenter, prospective, randomized trial evaluating a new hemostatic agent for spinal surgery. Spine (Phila Pa 1976). 2001; 26: 1645-1650.
27. Testini M, Marzaioli R, Lissidini G, et al. The effectiveness of Floseal matrix hemostatic agent in thyroid surgery: a prospective, randomized, control study. Langenbecks Arch Surg. 2009; 394: 837-842.
28. Ferri E, Armato E, Spinato G, Spinato R,. Focus harmonic scalpel compared to conventional haemostasis in open total thyroidectomy: a prospective randomized trial. Int J Otolaryngol. 2011; 2011: 357195.
29. Markogiannakis H, Kekis PB, Memos N, et al. Thyroid surgery with the new harmonic scalpel: a prospective randomized study. Surgery. 2011; 149: 411-415.
30. Foreman E, Aspinall S, Bliss RD, Lennard TW,. The use of the harmonic scalpel in thyroidectomy: "beyond the learning curve". Ann R Coll Surg Engl. 2009; 91: 214-216.
31. Lang BH, Ng SH, Lau LL, Cowling BJ, Wong KP,. A systematic review and meta-analysis comparing the efficacy and surgical outcomes of total thyroidectomy between harmonic scalpel versus Ligasure. Ann Surg Oncol. 2013; 20: 1918-1926.
32. Melck AL, Wiseman SM,. Harmonic scalpel compared to conventional hemostasis in thyroid surgery: a meta-analysis of randomized clinical trials. Int J Surg Oncol. 2010; 2010: 396079.
33. Ruggeri M, Dibidino R, Marchetti M, Lombardi CP, Raffaelli M, Cicchetti A,. The harmonic study: cost-effectiveness evaluation of the use of the ultrasonic scalpel in total thyroidectomy. Int J Technol Assess Health Care. 2012; 28: 259-264.
34. Tackett SM, Sugarman R, Kreuwel HT, Alvarez P, Nasso G,. Hospital economic impact from hemostatic matrix usage in cardiac surgery. J Med Econ. 2014; 17: 670-676.
35. Kilty SJ, Al-Hajry M, Al-Mutairi D, et al. Prospective clinical trial of gelatin-thrombin matrix as first line treatment of posterior epistaxis. Laryngoscope. 2014; 124: 38-42.